RecruitingNCT04611516
The Ear-Nose-Throat (ENT) Prospective International Cohort of PCD Patients (EPIC-PCD)
Sponsor
University of Bern
Enrollment
1,000 participants
Start Date
Mar 2, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The Ear-Nose-Throat (ENT) Prospective International Cohort of patients with Primary Ciliary Dyskinesia (EPIC-PCD) is a prospective observational clinical cohort study, set up as a multinational multi-centre study. It is embedded into routine patient care of participating reference centres for PCD and patients keep being managed according to local procedures and guidelines.
Eligibility
Inclusion Criteria2
- Diagnosis of PCD (clinical and test certified)
- Patient must undergo an ENT examination minimum once a year as part of their clinical follow-up
Exclusion Criteria1
- None
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04611516
Related Trials
A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine
NCT072746311 location
DCP (RaDiCo Cohort) (RaDiCo-DCP)
NCT0595147832 locations
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
NCT072888271 location
Living With Primary Ciliary Dyskinesia (Living With PCD)
NCT046024811 location
Swiss Primary Ciliary Dyskinesia Registry
NCT036062001 location